Multi-Industry Letter to FDA on Possible Use of 3rd Party Audit Data

ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.

ASTA sent a letter to Senator Durbin in March 2009 supporting legislation to reform the food safety system, providing comments on specific provisions included in the bill and offering to work with the Senator's staff on modifications that would facilitate implementation and assure the objectives are met.